Showing results (2201-2210 of 5,227) with videos related to

Sort By:
Pageof 523
Antiviral Research|November 14, 2017
APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcriptionYanmeng Chen, Jie Hu, Xuefei Cai, et al.
Antiviral Research|November 15, 2017
HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory elementTianlun Zhou, Timothy Block, Fei Liu, et al.
Antiviral Research|November 30, 2017
The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antiviralsAhmed Diab, Adrien Foca, Fabien Zoulim, et al.
Antiviral Research|September 3, 2017
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virusAtsushi Hamana, Yuki Takahashi, Takuro Uchida, et al.
Antiviral Research|September 27, 2017
Recombinant hemagglutinin proteins formulated in a novel PELC/CpG adjuvant for H7N9 subunit vaccine developmentTing-Hsuan Chen, Ying-Yu Liu, Jia-Tsrong Jan, et al.
Antiviral Research|July 9, 2016
Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technologyYa-Ting Yang, Yen-Hung Chow, Kuang-Nan Hsiao, et al.
Antiviral Research|September 21, 2017
A pilot study to expand treatment of chronic hepatitis C in resource-limited settingsPoonam Mathur, Emily Comstock, Edward McSweegan, et al.
Antiviral Research|September 24, 2017
Use of whole genome deep sequencing to define emerging minority variants in virus envelope genes in herpesvirus treated with novel antimicrobial K21Joshua G Tweedy, Bhupesh K Prusty, Ursula A Gompels
Antiviral Research|July 30, 2017
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patientsLouis Jansen, Matthijs R A Welkers, Karel A van Dort, et al.
Antiviral Research|August 6, 2017
Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B virusesYanmei Hu, Jiantao Zhang, Rami Ghassan Musharrafieh, et al.
Pageof 523